Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOMEZ
|
ENSG00000215271.6 | homeobox and leucine zipper encoding |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_23768453_23768685 | HOMEZ | 87 | 0.846243 | -0.72 | 2.8e-02 | Click! |
chr14_23754384_23754641 | HOMEZ | 814 | 0.378920 | 0.68 | 4.3e-02 | Click! |
chr14_23755778_23756110 | HOMEZ | 618 | 0.491761 | 0.58 | 1.1e-01 | Click! |
chr14_23756113_23756298 | HOMEZ | 879 | 0.346604 | 0.48 | 1.9e-01 | Click! |
chr14_23762827_23762978 | HOMEZ | 115 | 0.873513 | -0.43 | 2.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_195842946_195843347 | 3.88 |
TFRC |
transferrin receptor |
34086 |
0.13 |
chr8_2092048_2092232 | 2.97 |
MYOM2 |
myomesin 2 |
98956 |
0.09 |
chr14_102293722_102294111 | 2.96 |
CTD-2017C7.1 |
|
11952 |
0.15 |
chr17_1776335_1776696 | 2.68 |
RPA1 |
replication protein A1, 70kDa |
5814 |
0.17 |
chr10_30786899_30787172 | 2.56 |
ENSG00000239744 |
. |
57798 |
0.12 |
chr12_90258561_90258772 | 2.54 |
ENSG00000252823 |
. |
110830 |
0.07 |
chr11_14790471_14790758 | 2.43 |
CYP2R1 |
cytochrome P450, family 2, subfamily R, polypeptide 1 |
122583 |
0.05 |
chr14_98605614_98605900 | 2.39 |
C14orf64 |
chromosome 14 open reading frame 64 |
161296 |
0.04 |
chr1_198633258_198633639 | 2.18 |
RP11-553K8.5 |
|
2742 |
0.34 |
chr8_49863039_49863398 | 2.15 |
SNAI2 |
snail family zinc finger 2 |
28919 |
0.25 |
chr1_167471488_167471706 | 2.13 |
CD247 |
CD247 molecule |
16178 |
0.19 |
chr10_131968884_131969090 | 2.08 |
GLRX3 |
glutaredoxin 3 |
34324 |
0.24 |
chr10_35498028_35498338 | 2.08 |
RP11-324I22.3 |
|
1161 |
0.41 |
chr2_106375349_106375537 | 2.07 |
NCK2 |
NCK adaptor protein 2 |
13255 |
0.28 |
chr11_62607253_62607404 | 2.06 |
WDR74 |
WD repeat domain 74 |
195 |
0.82 |
chr1_90145962_90146113 | 2.06 |
LRRC8C |
leucine rich repeat containing 8 family, member C |
47406 |
0.12 |
chr9_5335867_5336116 | 2.05 |
RLN1 |
relaxin 1 |
3882 |
0.26 |
chr22_37619452_37619604 | 2.01 |
SSTR3 |
somatostatin receptor 3 |
11166 |
0.13 |
chr13_30921563_30921850 | 1.97 |
KATNAL1 |
katanin p60 subunit A-like 1 |
40085 |
0.18 |
chr5_56489439_56489693 | 1.96 |
GPBP1 |
GC-rich promoter binding protein 1 |
17793 |
0.22 |
chr1_149511225_149511376 | 1.95 |
ENSG00000212544 |
. |
2956 |
0.21 |
chr7_148617851_148618002 | 1.91 |
ENSG00000252310 |
. |
20654 |
0.13 |
chr12_40575871_40576022 | 1.89 |
LRRK2 |
leucine-rich repeat kinase 2 |
14600 |
0.23 |
chr2_191929273_191929916 | 1.87 |
ENSG00000231858 |
. |
43342 |
0.12 |
chr2_120686210_120686361 | 1.84 |
PTPN4 |
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
1067 |
0.58 |
chr1_147997051_147997202 | 1.83 |
ENSG00000212456 |
. |
2980 |
0.26 |
chr8_71065693_71065968 | 1.82 |
NCOA2 |
nuclear receptor coactivator 2 |
5135 |
0.28 |
chr7_3078977_3079128 | 1.81 |
CARD11 |
caspase recruitment domain family, member 11 |
4427 |
0.27 |
chr7_21398317_21398636 | 1.79 |
ENSG00000195024 |
. |
22505 |
0.21 |
chr17_37116490_37116784 | 1.79 |
FBXO47 |
F-box protein 47 |
7018 |
0.14 |
chr1_167589694_167589845 | 1.79 |
RCSD1 |
RCSD domain containing 1 |
9561 |
0.19 |
chr13_42077063_42077331 | 1.78 |
RGCC |
regulator of cell cycle |
45502 |
0.12 |
chr2_68947558_68947872 | 1.78 |
ARHGAP25 |
Rho GTPase activating protein 25 |
10081 |
0.25 |
chr6_128202143_128202376 | 1.76 |
THEMIS |
thymocyte selection associated |
19844 |
0.27 |
chr15_38775196_38775347 | 1.75 |
FAM98B |
family with sequence similarity 98, member B |
17724 |
0.17 |
chr14_106517901_106518168 | 1.75 |
IGHV3-7 |
immunoglobulin heavy variable 3-7 |
898 |
0.25 |
chr4_154710777_154711014 | 1.75 |
SFRP2 |
secreted frizzled-related protein 2 |
623 |
0.75 |
chr18_60872344_60872516 | 1.74 |
ENSG00000238988 |
. |
10532 |
0.23 |
chrX_19764292_19764574 | 1.73 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
96 |
0.98 |
chr9_35639982_35640133 | 1.72 |
RP11-331F9.3 |
|
2454 |
0.11 |
chr6_11382696_11383169 | 1.70 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
351 |
0.92 |
chr6_151772746_151772974 | 1.70 |
RMND1 |
required for meiotic nuclear division 1 homolog (S. cerevisiae) |
394 |
0.59 |
chr1_100855689_100855863 | 1.67 |
ENSG00000216067 |
. |
11445 |
0.2 |
chr3_177722273_177722502 | 1.67 |
ENSG00000199858 |
. |
3180 |
0.41 |
chr3_196291691_196292106 | 1.65 |
WDR53 |
WD repeat domain 53 |
2283 |
0.21 |
chr2_173298775_173298926 | 1.65 |
AC078883.4 |
|
5519 |
0.2 |
chr8_124516884_124517088 | 1.62 |
FBXO32 |
F-box protein 32 |
36460 |
0.15 |
chr12_68530648_68530810 | 1.60 |
IFNG |
interferon, gamma |
22798 |
0.24 |
chr1_161511152_161511506 | 1.59 |
FCGR3A |
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
8250 |
0.12 |
chr3_195843351_195843535 | 1.59 |
TFRC |
transferrin receptor |
34383 |
0.13 |
chr5_156625360_156625639 | 1.59 |
ITK |
IL2-inducible T-cell kinase |
17662 |
0.12 |
chr21_19155131_19155430 | 1.58 |
AL109761.5 |
|
10525 |
0.23 |
chrX_77054367_77054518 | 1.58 |
ATRX |
alpha thalassemia/mental retardation syndrome X-linked |
12740 |
0.21 |
chr18_29679004_29679408 | 1.57 |
ENSG00000238982 |
. |
4739 |
0.14 |
chr1_160416542_160416807 | 1.57 |
VANGL2 |
VANGL planar cell polarity protein 2 |
46298 |
0.09 |
chr1_148764071_148764222 | 1.57 |
ENSG00000206968 |
. |
2956 |
0.31 |
chr22_41251648_41251915 | 1.56 |
ST13 |
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) |
1179 |
0.3 |
chr12_112430467_112430685 | 1.56 |
TMEM116 |
transmembrane protein 116 |
13213 |
0.16 |
chr6_112075992_112076143 | 1.54 |
FYN |
FYN oncogene related to SRC, FGR, YES |
4250 |
0.31 |
chr19_3813101_3813594 | 1.54 |
MATK |
megakaryocyte-associated tyrosine kinase |
11220 |
0.11 |
chr10_32642138_32642445 | 1.53 |
RP11-135A24.2 |
|
5966 |
0.14 |
chr11_121162107_121162258 | 1.52 |
SC5D |
sterol-C5-desaturase |
980 |
0.7 |
chr2_143917354_143917505 | 1.52 |
RP11-190J23.1 |
|
12312 |
0.25 |
chr1_66822547_66823149 | 1.52 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
2783 |
0.4 |
chr12_29255913_29256179 | 1.52 |
ENSG00000222481 |
. |
17769 |
0.25 |
chr6_494073_494224 | 1.51 |
RP1-20B11.2 |
|
30023 |
0.23 |
chr6_130537365_130537658 | 1.51 |
SAMD3 |
sterile alpha motif domain containing 3 |
432 |
0.9 |
chr6_37009553_37009713 | 1.51 |
COX6A1P2 |
cytochrome c oxidase subunit VIa polypeptide 1 pseudogene 2 |
2974 |
0.26 |
chr3_59993838_59993993 | 1.50 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
36332 |
0.25 |
chr3_42597426_42598002 | 1.49 |
SEC22C |
SEC22 vesicle trafficking protein homolog C (S. cerevisiae) |
7410 |
0.14 |
chrY_1523320_1523573 | 1.49 |
NA |
NA |
> 106 |
NA |
chr17_20178582_20178828 | 1.49 |
ENSG00000252971 |
. |
14865 |
0.17 |
chr1_111437821_111438265 | 1.49 |
CD53 |
CD53 molecule |
22267 |
0.15 |
chr7_158616385_158616577 | 1.49 |
ESYT2 |
extended synaptotagmin-like protein 2 |
5682 |
0.26 |
chr2_97627578_97627763 | 1.49 |
ENSG00000252845 |
. |
5118 |
0.16 |
chrX_1573315_1573573 | 1.48 |
ASMTL |
acetylserotonin O-methyltransferase-like |
789 |
0.65 |
chr6_149405758_149405946 | 1.47 |
RP11-162J8.3 |
|
52143 |
0.14 |
chr6_128290581_128290732 | 1.46 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
38566 |
0.17 |
chr9_74524910_74525091 | 1.46 |
ABHD17B |
abhydrolase domain containing 17B |
658 |
0.62 |
chr16_68155574_68155725 | 1.45 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
1284 |
0.33 |
chr6_147525970_147526206 | 1.45 |
STXBP5-AS1 |
STXBP5 antisense RNA 1 |
338 |
0.57 |
chr11_108067830_108068158 | 1.45 |
ATM |
ataxia telangiectasia mutated |
25217 |
0.14 |
chr7_50360747_50361062 | 1.44 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
6341 |
0.3 |
chr12_68553257_68553408 | 1.44 |
IFNG |
interferon, gamma |
195 |
0.96 |
chr1_100868270_100868443 | 1.44 |
ENSG00000216067 |
. |
24025 |
0.18 |
chr21_34934879_34935141 | 1.44 |
SON |
SON DNA binding protein |
7655 |
0.13 |
chrX_78406329_78406539 | 1.44 |
GPR174 |
G protein-coupled receptor 174 |
20035 |
0.29 |
chr14_22562409_22562689 | 1.44 |
ENSG00000238634 |
. |
48338 |
0.17 |
chr7_50203640_50204043 | 1.43 |
AC020743.2 |
|
21422 |
0.21 |
chr1_28833699_28833856 | 1.43 |
SNHG3 |
small nucleolar RNA host gene 3 (non-protein coding) |
101 |
0.9 |
chr10_22939400_22939908 | 1.43 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
59012 |
0.15 |
chr7_158606442_158606622 | 1.43 |
ESYT2 |
extended synaptotagmin-like protein 2 |
15631 |
0.23 |
chr20_1653807_1654081 | 1.43 |
ENSG00000242348 |
. |
6938 |
0.17 |
chr6_106764194_106764345 | 1.43 |
ATG5 |
autophagy related 5 |
9023 |
0.17 |
chr12_62711223_62711384 | 1.42 |
USP15 |
ubiquitin specific peptidase 15 |
11927 |
0.2 |
chr13_24824909_24825522 | 1.42 |
SPATA13 |
spermatogenesis associated 13 |
617 |
0.7 |
chr2_114673068_114673219 | 1.42 |
ACTR3 |
ARP3 actin-related protein 3 homolog (yeast) |
24968 |
0.2 |
chr1_167571678_167571888 | 1.42 |
RCSD1 |
RCSD domain containing 1 |
27547 |
0.16 |
chr6_97371276_97371470 | 1.42 |
KLHL32 |
kelch-like family member 32 |
1232 |
0.48 |
chr2_8620238_8620557 | 1.42 |
AC011747.7 |
|
195499 |
0.03 |
chr6_53156340_53156626 | 1.41 |
ENSG00000264056 |
. |
14692 |
0.19 |
chr12_54893195_54893856 | 1.41 |
NCKAP1L |
NCK-associated protein 1-like |
957 |
0.48 |
chr6_53097510_53097661 | 1.41 |
ENSG00000206908 |
. |
13526 |
0.17 |
chr21_43835879_43836201 | 1.41 |
ENSG00000252619 |
. |
1662 |
0.28 |
chr8_129296618_129296930 | 1.41 |
ENSG00000201782 |
. |
64024 |
0.14 |
chr1_121293995_121294146 | 1.41 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
358133 |
0.01 |
chr6_12163053_12163430 | 1.41 |
HIVEP1 |
human immunodeficiency virus type I enhancer binding protein 1 |
37262 |
0.22 |
chr8_37738986_37739173 | 1.41 |
RAB11FIP1 |
RAB11 family interacting protein 1 (class I) |
3444 |
0.18 |
chr9_2026262_2026464 | 1.41 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
2656 |
0.35 |
chr9_100859905_100860165 | 1.40 |
TRIM14 |
tripartite motif containing 14 |
5192 |
0.21 |
chr17_7238988_7239233 | 1.40 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
738 |
0.35 |
chr2_99087473_99087624 | 1.40 |
INPP4A |
inositol polyphosphate-4-phosphatase, type I, 107kDa |
26135 |
0.2 |
chr2_202135550_202135981 | 1.39 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
1596 |
0.39 |
chr8_81052648_81052799 | 1.39 |
RP11-92K15.1 |
|
17636 |
0.19 |
chr3_151910786_151910994 | 1.39 |
MBNL1 |
muscleblind-like splicing regulator 1 |
74939 |
0.11 |
chr5_156654582_156654733 | 1.39 |
CTB-4E7.1 |
|
3267 |
0.17 |
chr5_93912907_93913170 | 1.39 |
ENSG00000211498 |
. |
1436 |
0.44 |
chr15_68379000_68379151 | 1.39 |
PIAS1 |
protein inhibitor of activated STAT, 1 |
32161 |
0.21 |
chr2_106711761_106712080 | 1.38 |
C2orf40 |
chromosome 2 open reading frame 40 |
29664 |
0.2 |
chr5_171387448_171387599 | 1.38 |
FBXW11 |
F-box and WD repeat domain containing 11 |
17237 |
0.25 |
chr11_118179196_118179378 | 1.38 |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
3673 |
0.16 |
chr2_182088298_182088620 | 1.38 |
ENSG00000266705 |
. |
81920 |
0.11 |
chr1_148602023_148602174 | 1.37 |
ENSG00000207205 |
. |
2974 |
0.33 |
chr12_46608026_46608177 | 1.37 |
SLC38A1 |
solute carrier family 38, member 1 |
53383 |
0.17 |
chr6_157181848_157181999 | 1.37 |
ARID1B |
AT rich interactive domain 1B (SWI1-like) |
40584 |
0.19 |
chr4_109035248_109035576 | 1.37 |
LEF1 |
lymphoid enhancer-binding factor 1 |
52045 |
0.14 |
chr8_2092374_2092525 | 1.36 |
MYOM2 |
myomesin 2 |
99265 |
0.08 |
chr2_230738283_230738434 | 1.36 |
TRIP12 |
thyroid hormone receptor interactor 12 |
14360 |
0.17 |
chr5_162940734_162940885 | 1.36 |
MAT2B |
methionine adenosyltransferase II, beta |
8189 |
0.18 |
chr2_144207551_144207702 | 1.35 |
AC096558.1 |
|
30724 |
0.23 |
chr1_161592599_161593034 | 1.34 |
FCGR3B |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
8006 |
0.12 |
chr16_79317454_79317605 | 1.34 |
ENSG00000222244 |
. |
19178 |
0.28 |
chr10_11185783_11186046 | 1.34 |
CELF2 |
CUGBP, Elav-like family member 2 |
21079 |
0.19 |
chr19_54879768_54880096 | 1.34 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
2126 |
0.19 |
chr11_102341530_102341808 | 1.34 |
RP11-315O6.2 |
HCG1815860; Uncharacterized protein |
3683 |
0.2 |
chr1_100908166_100908711 | 1.34 |
RP5-837M10.4 |
|
43115 |
0.14 |
chrX_119150535_119150686 | 1.34 |
RP4-755D9.1 |
|
19591 |
0.17 |
chr1_198631816_198632541 | 1.33 |
RP11-553K8.5 |
|
4012 |
0.29 |
chr10_6111810_6111968 | 1.33 |
IL2RA |
interleukin 2 receptor, alpha |
7601 |
0.16 |
chr12_9809071_9809277 | 1.33 |
RP11-705C15.3 |
|
1989 |
0.21 |
chr2_198769066_198769554 | 1.33 |
PLCL1 |
phospholipase C-like 1 |
94328 |
0.08 |
chr15_66176692_66176843 | 1.32 |
RAB11A |
RAB11A, member RAS oncogene family |
14416 |
0.19 |
chr13_109061568_109062120 | 1.32 |
ENSG00000223177 |
. |
108165 |
0.07 |
chr18_9121680_9121831 | 1.32 |
RP11-143J12.3 |
|
5880 |
0.17 |
chr10_35803187_35803338 | 1.32 |
GJD4 |
gap junction protein, delta 4, 40.1kDa |
91076 |
0.08 |
chr4_154413582_154413906 | 1.32 |
KIAA0922 |
KIAA0922 |
26243 |
0.22 |
chr12_92773237_92773489 | 1.32 |
RP11-693J15.4 |
|
41944 |
0.15 |
chr18_21586324_21586475 | 1.32 |
TTC39C |
tetratricopeptide repeat domain 39C |
7985 |
0.18 |
chr1_168504447_168504842 | 1.31 |
XCL2 |
chemokine (C motif) ligand 2 |
8591 |
0.25 |
chr6_11232229_11232517 | 1.31 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
518 |
0.84 |
chr11_117819899_117820198 | 1.31 |
TMPRSS13 |
transmembrane protease, serine 13 |
19874 |
0.16 |
chr13_42966290_42966473 | 1.31 |
AKAP11 |
A kinase (PRKA) anchor protein 11 |
120092 |
0.06 |
chr3_48552666_48552820 | 1.30 |
SHISA5 |
shisa family member 5 |
10484 |
0.1 |
chr2_238879197_238879348 | 1.30 |
UBE2F |
ubiquitin-conjugating enzyme E2F (putative) |
1837 |
0.38 |
chr14_99647139_99647315 | 1.30 |
AL162151.4 |
|
22474 |
0.23 |
chr2_179895564_179895758 | 1.29 |
ENSG00000252000 |
. |
7556 |
0.23 |
chr6_37143189_37143451 | 1.29 |
PIM1 |
pim-1 oncogene |
5341 |
0.2 |
chr5_146255527_146255678 | 1.29 |
PPP2R2B |
protein phosphatase 2, regulatory subunit B, beta |
2603 |
0.36 |
chr3_99594079_99594697 | 1.29 |
FILIP1L |
filamin A interacting protein 1-like |
560 |
0.83 |
chr5_80298134_80298285 | 1.29 |
CTC-459I6.1 |
|
41483 |
0.16 |
chr19_910573_910814 | 1.29 |
R3HDM4 |
R3H domain containing 4 |
2538 |
0.12 |
chr17_2171475_2171819 | 1.29 |
SMG6 |
SMG6 nonsense mediated mRNA decay factor |
2154 |
0.21 |
chr6_44946331_44946482 | 1.29 |
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
23159 |
0.28 |
chr11_121328693_121328910 | 1.29 |
RP11-730K11.1 |
|
5079 |
0.26 |
chr17_54678795_54679086 | 1.29 |
NOG |
noggin |
7880 |
0.31 |
chr22_42605437_42605588 | 1.29 |
TCF20 |
transcription factor 20 (AR1) |
702 |
0.68 |
chr15_60828599_60828948 | 1.28 |
CTD-2501E16.2 |
|
6601 |
0.21 |
chr1_161157104_161157573 | 1.28 |
B4GALT3 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 |
10051 |
0.06 |
chr12_121293047_121293198 | 1.28 |
SPPL3 |
signal peptide peptidase like 3 |
19662 |
0.17 |
chr2_106357251_106357402 | 1.28 |
NCK2 |
NCK adaptor protein 2 |
4028 |
0.35 |
chr10_8445227_8445412 | 1.28 |
ENSG00000212505 |
. |
253475 |
0.02 |
chr8_22396870_22397394 | 1.28 |
RP11-582J16.4 |
|
5786 |
0.12 |
chr5_130869288_130869613 | 1.28 |
RAPGEF6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
724 |
0.8 |
chr4_109236355_109236506 | 1.28 |
ENSG00000232021 |
. |
138986 |
0.05 |
chr7_50340668_50340819 | 1.27 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
3581 |
0.35 |
chr15_91143361_91143512 | 1.27 |
CTD-3065B20.2 |
|
3757 |
0.19 |
chr7_6522617_6522841 | 1.27 |
FLJ20306 |
CDNA FLJ20306 fis, clone HEP06881; Putative uncharacterized protein FLJ20306; Uncharacterized protein |
193 |
0.84 |
chr20_31561789_31561940 | 1.27 |
EFCAB8 |
EF-hand calcium binding domain 8 |
14213 |
0.15 |
chr5_40746541_40746747 | 1.27 |
TTC33 |
tetratricopeptide repeat domain 33 |
9433 |
0.18 |
chr12_65091217_65091368 | 1.27 |
AC025262.1 |
Mesenchymal stem cell protein DSC96; Uncharacterized protein |
963 |
0.5 |
chr13_95836619_95836770 | 1.27 |
ENSG00000238463 |
. |
25904 |
0.23 |
chr11_119112247_119112472 | 1.27 |
CBL |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
35607 |
0.08 |
chr1_90142608_90142759 | 1.27 |
LRRC8C |
leucine rich repeat containing 8 family, member C |
44052 |
0.12 |
chr1_110043711_110043925 | 1.27 |
CYB561D1 |
cytochrome b561 family, member D1 |
7081 |
0.11 |
chr7_28011221_28011372 | 1.26 |
JAZF1 |
JAZF zinc finger 1 |
20379 |
0.24 |
chr4_109069029_109069225 | 1.26 |
LEF1 |
lymphoid enhancer-binding factor 1 |
18330 |
0.21 |
chr14_100549756_100549907 | 1.26 |
CTD-2376I20.1 |
|
8616 |
0.14 |
chr9_71635119_71635544 | 1.26 |
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
6292 |
0.23 |
chr3_60039956_60040107 | 1.26 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
82448 |
0.12 |
chr5_49997563_49997796 | 1.26 |
PARP8 |
poly (ADP-ribose) polymerase family, member 8 |
34288 |
0.25 |
chr10_11217517_11217809 | 1.26 |
RP3-323N1.2 |
|
4324 |
0.25 |
chr14_102295296_102295488 | 1.26 |
CTD-2017C7.1 |
|
10476 |
0.15 |
chr14_50997962_50998303 | 1.25 |
MAP4K5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
1058 |
0.44 |
chr16_11774421_11774582 | 1.25 |
SNN |
stannin |
12231 |
0.17 |
chr6_4009379_4009530 | 1.25 |
RP3-406P24.3 |
|
11995 |
0.15 |
chr5_75710823_75710974 | 1.25 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
10649 |
0.28 |
chr14_71402250_71402430 | 1.25 |
PCNX |
pecanex homolog (Drosophila) |
27884 |
0.24 |
chr5_75768488_75768786 | 1.24 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
68388 |
0.12 |
chr22_40719217_40719484 | 1.24 |
ADSL |
adenylosuccinate lyase |
23157 |
0.17 |
chr14_102297637_102297788 | 1.24 |
CTD-2017C7.1 |
|
8156 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 7.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.4 | 7.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.2 | 4.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.1 | 1.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.0 | 2.9 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
1.0 | 2.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.9 | 7.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.9 | 2.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.9 | 1.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.8 | 6.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.8 | 3.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.8 | 3.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 2.4 | GO:0072182 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.8 | 2.3 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.8 | 1.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.7 | 2.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 1.5 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.7 | 3.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 2.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.7 | 1.4 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.7 | 2.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.7 | 3.4 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.7 | 2.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.7 | 4.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.7 | 2.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 2.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.6 | 2.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.6 | 2.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.6 | 0.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.5 | 0.5 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.5 | 2.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.5 | 2.7 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.5 | 1.6 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.5 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.5 | 4.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 1.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 1.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.5 | 1.5 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.5 | 1.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 1.4 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.5 | 1.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.5 | 1.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 33.8 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.5 | 1.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.5 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.5 | 1.4 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.5 | 1.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 1.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 1.4 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.4 | 4.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 1.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.4 | 2.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.4 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.4 | 2.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 1.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 1.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.4 | 1.2 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.4 | 7.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 1.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.4 | 1.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 1.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 0.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 4.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 1.8 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.4 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.4 | 2.5 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.4 | 1.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.4 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 0.7 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.4 | 2.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 3.8 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.3 | 1.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 2.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.3 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 1.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.3 | 0.7 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 0.3 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.3 | 1.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.0 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.3 | 1.0 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 0.6 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.3 | 1.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 1.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.3 | 1.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.3 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.3 | 0.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 0.3 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.3 | 1.5 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.3 | 0.3 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.3 | 1.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 0.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.3 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 2.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 1.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.3 | 0.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.3 | 0.3 | GO:1903707 | negative regulation of hemopoiesis(GO:1903707) |
0.3 | 2.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.3 | 1.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 3.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 0.3 | GO:0031223 | auditory behavior(GO:0031223) |
0.3 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 2.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 0.3 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 1.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 8.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 0.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 0.3 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.3 | 0.8 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.3 | 0.8 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.3 | 0.8 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 0.8 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.3 | 1.8 | GO:0002837 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.3 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 0.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.2 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation(GO:0043367) |
0.2 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 1.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 0.5 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 1.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 4.2 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 5.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 1.2 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.2 | 1.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 1.0 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.5 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 1.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 2.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 0.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 1.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.7 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 0.5 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 1.6 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 1.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.5 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.2 | 0.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 1.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 3.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 5.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 1.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 1.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 1.3 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.4 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.2 | 1.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.2 | 0.8 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.2 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 1.2 | GO:0036314 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.2 | 0.2 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 1.4 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 1.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.8 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.2 | 0.6 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 7.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.6 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.2 | 0.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 3.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 1.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.8 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.2 | 0.6 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.2 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 2.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 1.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.6 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.3 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 1.1 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 0.6 | GO:0001821 | histamine secretion(GO:0001821) |
0.2 | 0.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.6 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.4 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 0.7 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.9 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 2.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.5 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 14.4 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.5 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 0.7 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 3.5 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.7 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 | 0.2 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.3 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.9 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 0.7 | GO:0021612 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.2 | 0.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 0.5 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.2 | 0.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 1.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.3 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.2 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 2.7 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.2 | 0.5 | GO:0001832 | blastocyst growth(GO:0001832) |
0.2 | 0.7 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.2 | 1.4 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.5 | GO:0072243 | metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.2 | 0.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.2 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 1.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.7 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 2.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 2.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 1.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 2.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.2 | GO:0031058 | positive regulation of histone modification(GO:0031058) |
0.2 | 1.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.2 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.2 | 0.8 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 1.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 1.0 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.2 | 2.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.3 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.5 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.6 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.2 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.2 | 1.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.5 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.2 | GO:0032527 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 0.8 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.2 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 0.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.2 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.3 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.1 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 1.3 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 1.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 1.6 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.4 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.4 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.3 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.4 | GO:0035092 | spermatid nucleus differentiation(GO:0007289) sperm chromatin condensation(GO:0035092) |
0.1 | 2.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.3 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.4 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.3 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.8 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.7 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.5 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 2.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.3 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 7.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 2.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 2.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 1.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 2.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.1 | GO:0045617 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 1.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.8 | GO:0030032 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.1 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 1.1 | GO:0048937 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.1 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.9 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 6.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.5 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 1.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 1.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.6 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 1.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 1.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.3 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 7.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.1 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.1 | 0.2 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.4 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.2 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 1.8 | GO:0022618 | ribonucleoprotein complex assembly(GO:0022618) |
0.1 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) histone H4-R3 methylation(GO:0043985) |
0.1 | 3.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.2 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.7 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.9 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 1.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 1.5 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 0.7 | GO:1904018 | positive regulation of angiogenesis(GO:0045766) positive regulation of vasculature development(GO:1904018) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.3 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 1.0 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 2.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.1 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.5 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.8 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.1 | 3.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.5 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 1.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 22.8 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.1 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.2 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.2 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 1.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 1.7 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.1 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.1 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 3.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.4 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) positive regulation of dendrite development(GO:1900006) |
0.1 | 0.1 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.3 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.8 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.6 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.1 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.7 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 1.6 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.5 | GO:0071326 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.1 | 0.5 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 0.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 2.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.9 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 2.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 4.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.1 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 3.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.2 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 4.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.7 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 1.5 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 0.5 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.3 | GO:0019614 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.1 | GO:0042695 | thelarche(GO:0042695) development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 3.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 1.7 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) positive regulation of phospholipase activity(GO:0010518) positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.2 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.1 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.5 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) obsolete positive regulation of natriuresis(GO:0003079) |
0.1 | 0.4 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.2 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.1 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.7 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.2 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.8 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 3.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0032637 | interleukin-8 production(GO:0032637) |
0.1 | 0.3 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.1 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.8 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 2.5 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.8 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 2.1 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 1.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 4.4 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.4 | GO:0061371 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.8 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.1 | 1.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.4 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.9 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0072176 | nephric duct development(GO:0072176) mesonephric duct development(GO:0072177) nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 7.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.8 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.7 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.3 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.7 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.2 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 0.4 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 17.7 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 1.8 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 0.4 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.3 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.1 | 0.8 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) regulation of regulated secretory pathway(GO:1903305) |
0.1 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 6.2 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.0 | GO:0097193 | intrinsic apoptotic signaling pathway(GO:0097193) |
0.1 | 2.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 1.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.2 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.1 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.7 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 1.6 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.4 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 1.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 0.3 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.5 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.7 | GO:1903039 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.1 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.2 | GO:1903008 | organelle disassembly(GO:1903008) |
0.1 | 0.2 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.0 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.7 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.1 | 6.0 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 1.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0048708 | astrocyte differentiation(GO:0048708) |
0.1 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 1.0 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.2 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.4 | GO:0046039 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) GTP metabolic process(GO:0046039) UTP metabolic process(GO:0046051) |
0.1 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 1.5 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 0.4 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 10.6 | GO:0006325 | chromatin organization(GO:0006325) |
0.1 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:0050671 | positive regulation of lymphocyte proliferation(GO:0050671) |
0.0 | 0.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.3 | GO:0095500 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.0 | 0.7 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.2 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.0 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 1.0 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.2 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.5 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.0 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.2 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.2 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.0 | 0.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.0 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.8 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.3 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.5 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.2 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.0 | 0.1 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 1.3 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.0 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.9 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.0 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.0 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0046888 | negative regulation of hormone secretion(GO:0046888) |
0.0 | 0.0 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.0 | 0.0 | GO:0014808 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.4 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.3 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.0 | 0.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.0 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.0 | 1.1 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.1 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.2 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0034110 | regulation of homotypic cell-cell adhesion(GO:0034110) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 3.0 | GO:0043632 | modification-dependent protein catabolic process(GO:0019941) modification-dependent macromolecule catabolic process(GO:0043632) |
0.0 | 0.7 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 1.2 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:1902117 | regulation of sarcomere organization(GO:0060297) positive regulation of sarcomere organization(GO:0060298) positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.0 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.6 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.4 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.3 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.0 | 1.5 | GO:0006887 | exocytosis(GO:0006887) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.0 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.2 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.0 | 0.0 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.0 | 0.0 | GO:0051196 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.5 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.8 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.5 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 4.6 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 3.7 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 2.0 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.0 | GO:1903729 | regulation of plasma membrane organization(GO:1903729) |
0.0 | 0.2 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.0 | 0.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.0 | 0.0 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.0 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.7 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0050704 | regulation of interleukin-1 secretion(GO:0050704) positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 6.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.0 | 0.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0051324 | prophase(GO:0051324) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.9 | 7.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 2.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.7 | 2.1 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 7.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 2.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.6 | 1.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.6 | 0.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.5 | 5.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.5 | 2.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.4 | 0.8 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.4 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 3.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 4.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.7 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 3.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 2.0 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 6.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 2.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 0.6 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.3 | 0.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.3 | 0.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 1.9 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 1.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 0.8 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.0 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 2.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 2.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 2.0 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 2.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.9 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 1.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 2.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 7.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 1.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 6.7 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 1.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 1.2 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 2.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.2 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.9 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.2 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.2 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 1.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.8 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 0.3 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 3.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.6 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 3.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 3.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 1.8 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 6.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 2.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 2.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 3.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 5.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.5 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.7 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 5.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 12.6 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 12.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 5.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.4 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 2.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.5 | GO:0098573 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.9 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 2.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 4.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 7.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 12.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 7.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 7.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.4 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.4 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.7 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.4 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 3.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 3.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 5.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 3.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 2.0 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.8 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 3.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.8 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 38.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 1.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 4.4 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 3.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 1.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 6.3 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.1 | 2.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.7 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 39.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 71.1 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 1.1 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.8 | GO:1990777 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 2.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 6.4 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 1.6 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.7 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.1 | GO:0031967 | organelle envelope(GO:0031967) |
0.1 | 22.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.3 | GO:0016529 | sarcoplasm(GO:0016528) sarcoplasmic reticulum(GO:0016529) |
0.0 | 1.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 7.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 1.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 2.2 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 109.2 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 1.8 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 2.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 1.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 10.3 | GO:0044429 | mitochondrial part(GO:0044429) |
0.0 | 0.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 2.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.4 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.3 | GO:0030313 | cell envelope(GO:0030313) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0044304 | main axon(GO:0044304) |
0.0 | 9.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.0 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 0.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.4 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 61.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 1.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.1 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.0 | 1.4 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 15.7 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.0 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 3.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.0 | 3.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.9 | 3.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.9 | 4.3 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.8 | 2.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.8 | 2.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.8 | 11.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 2.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 5.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 5.4 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.6 | 2.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 1.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 3.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 7.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.5 | 2.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 3.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 2.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 2.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 4.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 1.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 2.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 0.8 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 1.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.4 | 1.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 6.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 2.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 2.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 1.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 2.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 1.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 4.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 2.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 2.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 2.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.3 | 4.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.3 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.3 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 6.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 1.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 7.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 1.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 0.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 0.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 0.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.9 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 0.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 3.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 0.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 2.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 10.1 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 2.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.9 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 5.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 1.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 1.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 1.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 1.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 4.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 0.8 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 0.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 3.0 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.3 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 6.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.2 | 2.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 2.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 4.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 2.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 8.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 1.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.1 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 0.6 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 4.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 5.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 9.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 1.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.6 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.9 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.2 | 0.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 0.5 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.2 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 2.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 5.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 1.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.2 | 0.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 3.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 0.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.5 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 1.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 1.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 2.6 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 2.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.2 | 2.1 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 5.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 4.9 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.2 | 4.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 8.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 1.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 7.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.6 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 4.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 2.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 3.5 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 4.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 2.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 4.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 10.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 5.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.5 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 4.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 2.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.8 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.7 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 4.0 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 2.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 5.3 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 2.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 2.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 1.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 2.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 1.3 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 4.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.6 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 16.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.4 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.1 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 46.6 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.3 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.6 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 4.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 2.1 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 6.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.9 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 19.1 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 6.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 1.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 4.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 6.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 1.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 9.4 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.1 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 2.0 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.2 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.2 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 1.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 77.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.7 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 1.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.3 | GO:0016653 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 4.3 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 12.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 3.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 2.9 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 1.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.0 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 3.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 5.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 7.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 37.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 1.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.6 | 15.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 9.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 4.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 18.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 4.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 2.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 13.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 7.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 8.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 2.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 5.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 8.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 10.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 7.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 4.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 6.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 2.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 1.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 4.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 8.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 3.1 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 1.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 7.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 7.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 5.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 5.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 4.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 10.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 8.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.8 | 11.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 0.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.7 | 0.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.7 | 15.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 1.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 7.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 6.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 11.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 9.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 6.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 3.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 1.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 0.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.4 | 8.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 5.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 3.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 6.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 2.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 1.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 4.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 0.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 3.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 2.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 3.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 4.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 2.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 10.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 3.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.2 | 6.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 3.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 3.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 4.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 0.8 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 2.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 4.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 3.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 5.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 2.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 3.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 2.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 2.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 2.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 3.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 0.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 3.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 3.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 4.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.7 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 4.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 4.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 2.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 7.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 13.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 4.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 7.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 3.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 5.8 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 4.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 1.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.8 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.1 | 2.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 6.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 2.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.2 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 4.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.6 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 2.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 4.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 10.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 1.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.0 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.0 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 4.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |